Sign inJoin waitlistJoin the waitlist

MB

Michael Bernstein

Medical Director, Strategic Partnerships · New York Presbyterian Hospital

Credentials: · · ·

History

Strategic Partnerships · New York Presbyterian Hospital
Present

University of Texas M D Anderson Cancer Center
2014–2015
Radiation Oncology
Montefiore Einstein
2010–2014
Radiation Oncology
University of Texas M D Anderson Cancer Center
2010–2013
Preliminary or Transitional Year
2009–2010
Albert Einstein College of Medicine
2005–2009

Research

Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?
Review · Nature Reviews Clinical Oncology · 2016 · First of 4 authors · 332 citations
Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing
International journal of radiation oncology · 2016 · 126 citations
In the field: exploiting the untapped potential of immunogenic modulation by radiation in combination with immunotherapy for the treatment of cancer
Frontiers in Oncology · 2012 · 88 citations

AK
Atif Khan
9 papers
LB
Lior Braunstein
9 papers
BM
Boris Mueller
7 papers
JC
John Cuaron
7 papers
Simon Powell
7 papers
BM
Beryl McCormick
6 papers
AX
Amy Xu
5 papers
IC
Isabelle Choi
5 papers
Chandan Guha
4 papers
Erin Gillespie
3 papers
Shalom Kalnicki
3 papers
Amol Ghia
2 papers